Integral Ad Science Holding Corp. (NASDAQ:IAS – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the stock, MarketBeat reports. Six analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $13.15.
A number of analysts have recently issued reports on IAS shares. Morgan Stanley lowered their price objective on Integral Ad Science from $13.50 to $12.50 and set an “equal weight” rating on the stock in a research report on Thursday, April 17th. Baird R W lowered shares of Integral Ad Science from a “strong-buy” rating to a “hold” rating in a report on Friday, March 28th. Scotiabank started coverage on shares of Integral Ad Science in a research note on Friday, February 28th. They issued a “sector perform” rating and a $12.00 price objective for the company. Barclays decreased their target price on shares of Integral Ad Science from $14.00 to $7.00 and set an “equal weight” rating on the stock in a research report on Monday, April 21st. Finally, Truist Financial increased their price target on shares of Integral Ad Science from $16.00 to $17.00 and gave the stock a “buy” rating in a research report on Monday, March 3rd.
Check Out Our Latest Analysis on IAS
Insider Buying and Selling at Integral Ad Science
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in IAS. Alyeska Investment Group L.P. bought a new stake in shares of Integral Ad Science in the 4th quarter valued at about $41,543,000. Dimensional Fund Advisors LP boosted its holdings in Integral Ad Science by 18.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company’s stock valued at $39,567,000 after acquiring an additional 580,323 shares during the last quarter. Clearline Capital LP bought a new stake in Integral Ad Science in the fourth quarter valued at approximately $3,949,000. Invenomic Capital Management LP increased its position in Integral Ad Science by 52.9% during the 4th quarter. Invenomic Capital Management LP now owns 895,061 shares of the company’s stock valued at $9,344,000 after purchasing an additional 309,752 shares during the period. Finally, Ararat Capital Management LP raised its holdings in Integral Ad Science by 13.4% during the 4th quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company’s stock worth $23,823,000 after purchasing an additional 269,346 shares during the last quarter. Institutional investors own 95.78% of the company’s stock.
Integral Ad Science Stock Down 0.9%
Shares of Integral Ad Science stock opened at $7.72 on Wednesday. Integral Ad Science has a 12-month low of $6.26 and a 12-month high of $13.62. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. The stock has a 50 day moving average price of $7.86 and a two-hundred day moving average price of $9.73. The stock has a market capitalization of $1.26 billion, a P/E ratio of 38.60, a PEG ratio of 1.06 and a beta of 1.55.
Integral Ad Science (NASDAQ:IAS – Get Free Report) last announced its earnings results on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business had revenue of $153.00 million for the quarter, compared to the consensus estimate of $148.83 million. During the same quarter in the previous year, the company earned $0.06 EPS. Integral Ad Science’s revenue for the quarter was up 13.9% compared to the same quarter last year. Equities analysts expect that Integral Ad Science will post 0.26 earnings per share for the current year.
About Integral Ad Science
Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.
Read More
- Five stocks we like better than Integral Ad Science
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Constellation Powers Up With Reinforced AI Data Center Strategy
- 5 Top Rated Dividend Stocks to Consider
- Top Analyst-Rated Healthcare Stocks to Watch Now
- What is the MACD Indicator and How to Use it in Your Trading
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.